Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 3 | $460,539 |
Sells | 48 | $11,227,297 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
14 Aug 2024 17:10 | IRWD | IRONWOOD PHARMACEUTICALS INC | JOHN MINARDO | Chief Legal Officer | 12 Aug 2024 | Sale | 9,910 | 4.27 | 42,316 | D |
14 Aug 2024 17:08 | IRWD | IRONWOOD PHARMACEUTICALS INC | SILVER RONALD | Principal Accounting Officer | 12 Aug 2024 | Sale | 3,107 | 4.27 | 13,267 | D |
12 Jun 2024 16:05 | IRWD | IRONWOOD PHARMACEUTICALS INC | MCHUGH JULIE | Director | 10 Jun 2024 | Sale | 22,766 | 6.29 | 143,198 | D |
10 Jun 2024 16:58 | IRWD | IRONWOOD PHARMACEUTICALS INC | MOUKHEIBIR CATHERINE | Director | 07 Jun 2024 | Sale | 35,574 | 6.61 | 235,144 | D |
10 Jun 2024 16:58 | IRWD | IRONWOOD PHARMACEUTICALS INC | MOUKHEIBIR CATHERINE | Director | 06 Jun 2024 | Sale | 44,426 | 6.36 | 282,549 | D |
22 May 2024 16:05 | IRWD | IRONWOOD PHARMACEUTICALS INC | MCCOURT THOMAS A | Chief Executive Officer | 20 May 2024 | Sale | 67,618 | 6.45 | 436,136 | D |
22 May 2024 16:05 | IRWD | IRONWOOD PHARMACEUTICALS INC | DAVIS ANDREW | SVP, Chief Business Officer | 20 May 2024 | Sale | 22,725 | 6.45 | 146,576 | D |
22 May 2024 16:05 | IRWD | IRONWOOD PHARMACEUTICALS INC | SHETZLINE MICHAEL | CMO,SVP,Head-Res&Drug | 20 May 2024 | Sale | 16,128 | 6.45 | 104,026 | D |
22 May 2024 16:05 | IRWD | IRONWOOD PHARMACEUTICALS INC | JOHN MINARDO | Chief Legal Officer | 20 May 2024 | Sale | 17,404 | 6.45 | 112,256 | D |
08 Mar 2024 16:05 | IRWD | IRONWOOD PHARMACEUTICALS INC | DUANE JON R | Director | 06 Mar 2024 | Purchase | 6,920 | 8.7 | 60,204 | D |
06 Mar 2024 16:05 | IRWD | IRONWOOD PHARMACEUTICALS INC | EMANY SRAVAN KUMAR | SVP, Chief Financial Officer | 04 Mar 2024 | Purchase | 10,684 | 9.38 | 100,216 | D |
14 Feb 2024 21:01 | IRWD | IRONWOOD PHARMACEUTICALS INC | JOHN MINARDO | Chief Legal Officer | 12 Feb 2024 | Sale | 47,380 | 15.24 | 722,071 | D |
14 Feb 2024 20:53 | IRWD | IRONWOOD PHARMACEUTICALS INC | SHETZLINE MICHAEL | CMO,SVP,Head-Res&Drug | 12 Feb 2024 | Sale | 38,618 | 15.24 | 588,538 | D |
14 Feb 2024 20:50 | IRWD | IRONWOOD PHARMACEUTICALS INC | SILVER RONALD | Principal Accounting Officer | 12 Feb 2024 | Sale | 7,908 | 15.24 | 120,518 | D |
14 Feb 2024 20:42 | IRWD | IRONWOOD PHARMACEUTICALS INC | DAVIS ANDREW | SVP, Chief Business Officer | 12 Feb 2024 | Sale | 9,846 | 15.24 | 150,053 | D |
14 Feb 2024 20:35 | IRWD | IRONWOOD PHARMACEUTICALS INC | MCCOURT THOMAS A | Chief Executive Officer | 12 Feb 2024 | Sale | 177,164 | 15.24 | 2,699,979 | D |
18 Dec 2023 16:09 | IRWD | IRONWOOD PHARMACEUTICALS INC | KESSLER MARLA L | Director | 14 Dec 2023 | Sale | 9,926 | 11.19 | 111,072 | D |
22 Nov 2023 16:05 | IRWD | IRONWOOD PHARMACEUTICALS INC | DAVIS ANDREW | SVP, Chief Business Officer | 20 Nov 2023 | Sale | 3,287 | 9.69 | 31,851 | D |
18 Sep 2023 17:07 | IRWD | IRONWOOD PHARMACEUTICALS INC | EMANY SRAVAN KUMAR | SVP, Chief Financial Officer | 15 Sep 2023 | Purchase | 36,072 | 8.32 | 300,119 | D |
16 Aug 2023 16:21 | IRWD | IRONWOOD PHARMACEUTICALS INC | SILVER RONALD | Principal Accounting Officer | 14 Aug 2023 | Sale | 1,976 | 10.04 | 19,839 | D |
16 Aug 2023 16:20 | IRWD | IRONWOOD PHARMACEUTICALS INC | JOHN MINARDO | Chief Legal Officer | 14 Aug 2023 | Sale | 7,045 | 10.04 | 70,732 | D |
01 Jun 2023 17:45 | IRWD | IRONWOOD PHARMACEUTICALS INC | MCCOURT THOMAS A | Chief Executive Officer | 30 May 2023 | Sale | 26,632 | 10.7 | 284,962 | D |
24 May 2023 16:05 | IRWD | IRONWOOD PHARMACEUTICALS INC | SHETZLINE MICHAEL | CMO,SVP,Head-Res&Drug | 22 May 2023 | Sale | 10,324 | 10.12 | 104,479 | D |
24 May 2023 16:05 | IRWD | IRONWOOD PHARMACEUTICALS INC | DAVIS ANDREW | SVP, Chief Business Officer | 22 May 2023 | Sale | 6,305 | 10.12 | 63,807 | D |
24 May 2023 16:05 | IRWD | IRONWOOD PHARMACEUTICALS INC | MCCOURT THOMAS A | Chief Executive Officer | 22 May 2023 | Sale | 36,000 | 10.12 | 364,320 | D |
10 May 2023 16:05 | IRWD | IRONWOOD PHARMACEUTICALS INC | MCCOURT THOMAS A | Chief Executive Officer | 08 May 2023 | Sale | 21,148 | 10.62 | 224,592 | D |
29 Mar 2023 16:05 | IRWD | IRONWOOD PHARMACEUTICALS INC | MCCOURT THOMAS A | Chief Executive Officer | 27 Mar 2023 | Sale | 46,129 | 10.67 | 492,196 | D |
07 Mar 2023 16:05 | IRWD | IRONWOOD PHARMACEUTICALS INC | MCCOURT THOMAS A | Chief Executive Officer | 03 Mar 2023 | Sale | 33,756 | 11.22 | 378,742 | D |
01 Mar 2023 18:25 | IRWD | IRONWOOD PHARMACEUTICALS INC | SILVER RONALD | Principal Accounting Officer | 28 Feb 2023 | Sale | 3,049 | 11.31 | 34,484 | D |
01 Mar 2023 18:25 | IRWD | IRONWOOD PHARMACEUTICALS INC | SILVER RONALD | Principal Accounting Officer | 27 Feb 2023 | Sale | 2,929 | 11.41 | 33,420 | D |
01 Mar 2023 18:24 | IRWD | IRONWOOD PHARMACEUTICALS INC | RICKARD JASON | SVP, Chief Operating Officer | 28 Feb 2023 | Sale | 3,442 | 11.31 | 38,929 | D |
01 Mar 2023 18:24 | IRWD | IRONWOOD PHARMACEUTICALS INC | RICKARD JASON | SVP, Chief Operating Officer | 28 Feb 2023 | Sale | 13,987 | 11.31 | 158,193 | D |
01 Mar 2023 18:24 | IRWD | IRONWOOD PHARMACEUTICALS INC | RICKARD JASON | SVP, Chief Operating Officer | 27 Feb 2023 | Sale | 3,308 | 11.41 | 37,744 | D |
01 Mar 2023 18:24 | IRWD | IRONWOOD PHARMACEUTICALS INC | RICKARD JASON | SVP, Chief Operating Officer | 27 Feb 2023 | Sale | 13,438 | 11.41 | 153,328 | D |
01 Mar 2023 18:22 | IRWD | IRONWOOD PHARMACEUTICALS INC | MCCOURT THOMAS A | Chief Executive Officer | 28 Feb 2023 | Sale | 4,588 | 11.31 | 51,890 | D |
01 Mar 2023 18:22 | IRWD | IRONWOOD PHARMACEUTICALS INC | MCCOURT THOMAS A | Chief Executive Officer | 28 Feb 2023 | Sale | 26,639 | 11.31 | 301,287 | D |
01 Mar 2023 18:22 | IRWD | IRONWOOD PHARMACEUTICALS INC | MCCOURT THOMAS A | Chief Executive Officer | 27 Feb 2023 | Sale | 4,409 | 11.41 | 50,307 | D |
01 Mar 2023 18:22 | IRWD | IRONWOOD PHARMACEUTICALS INC | MCCOURT THOMAS A | Chief Executive Officer | 27 Feb 2023 | Sale | 25,595 | 11.41 | 292,039 | D |
01 Mar 2023 18:21 | IRWD | IRONWOOD PHARMACEUTICALS INC | SHETZLINE MICHAEL | CMO,SVP,Head-Res&Drug | 28 Feb 2023 | Sale | 2,416 | 11.31 | 27,325 | D |
01 Mar 2023 18:21 | IRWD | IRONWOOD PHARMACEUTICALS INC | SHETZLINE MICHAEL | CMO,SVP,Head-Res&Drug | 28 Feb 2023 | Sale | 7,438 | 11.31 | 84,124 | D |
01 Mar 2023 18:21 | IRWD | IRONWOOD PHARMACEUTICALS INC | SHETZLINE MICHAEL | CMO,SVP,Head-Res&Drug | 27 Feb 2023 | Sale | 2,322 | 11.41 | 26,494 | D |
01 Mar 2023 18:21 | IRWD | IRONWOOD PHARMACEUTICALS INC | SHETZLINE MICHAEL | CMO,SVP,Head-Res&Drug | 27 Feb 2023 | Sale | 7,146 | 11.41 | 81,536 | D |
01 Mar 2023 18:19 | IRWD | IRONWOOD PHARMACEUTICALS INC | JOHN MINARDO | Chief Legal Officer | 28 Feb 2023 | Sale | 3,415 | 11.31 | 38,624 | D |
01 Mar 2023 18:19 | IRWD | IRONWOOD PHARMACEUTICALS INC | JOHN MINARDO | Chief Legal Officer | 27 Feb 2023 | Sale | 3,282 | 11.41 | 37,448 | D |
01 Mar 2023 18:17 | IRWD | IRONWOOD PHARMACEUTICALS INC | DAVIS ANDREW | SVP, Chief Business Officer | 28 Feb 2023 | Sale | 1,822 | 11.31 | 20,607 | D |
01 Mar 2023 18:17 | IRWD | IRONWOOD PHARMACEUTICALS INC | DAVIS ANDREW | SVP, Chief Business Officer | 27 Feb 2023 | Sale | 1,751 | 11.41 | 19,979 | D |
09 Jan 2023 16:05 | IRWD | IRONWOOD PHARMACEUTICALS INC | MCCOURT THOMAS A | Chief Executive Officer | 05 Jan 2023 | Sale | 110,962 | 12.07 | 1,339,311 | D |
16 Dec 2022 16:05 | IRWD | IRONWOOD PHARMACEUTICALS INC | RICKARD JASON | SVP, Chief Operating Officer | 14 Dec 2022 | Sale | 27,000 | 12.39 | 334,530 | D |
23 Nov 2022 16:05 | IRWD | IRONWOOD PHARMACEUTICALS INC | EMANY SRAVAN KUMAR | SVP, Chief Financial Officer | 21 Nov 2022 | Sale | 6,578 | 11.56 | 76,042 | D |
23 Nov 2022 16:05 | IRWD | IRONWOOD PHARMACEUTICALS INC | SILVER RONALD | Principal Accounting Officer | 21 Nov 2022 | Sale | 682 | 11.56 | 7,884 | D |
23 Nov 2022 16:05 | IRWD | IRONWOOD PHARMACEUTICALS INC | DAVIS ANDREW | SVP, Chief Business Officer | 21 Nov 2022 | Sale | 3,335 | 11.56 | 38,553 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)